Why WPP PLC, AstraZeneca plc and Meggitt plc Should Beat The FTSE 100 Today

WPP PLC (LON: WPP), AstraZeneca plc (LON: AZN) and Meggitt plc (LON: MGGT) bring us good news.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

So for months, every time the prospect of US stimulus-reduction is even mentioned, investors run for the hills and the FTSE 100 (FTSEINDICES: ^FTSE) takes a tumble. Then when it actually happens — the Federal Reserve has decided to cut bond purchases by $10bn per month to $75bn — the FTSE rises! It’s up 64 points since the decision was known, to 6,556.

It might be the simultaneous commitment to maintaining low interest rates that has led to this reaction, but it shows that trying to second-guess the market’s short-term movements is a mug’s game.

Anyway, which individual FTSE 100 shares are rising today? Here are three:

WPP

WPP (LSE: WPP) shares gained 30p (2.3%) to 1,328p on the announcement of a new acquisition by the marketing giant.

One of WPP’s subsidiaries, GroupM, is to buy up a majority stake in ClickMedia which operates in Vietnam. Described as “a full service social media marketing firm“, ClickMedia counts Unilever and Estee Lauder amongst its customers, and had revenues of 23.7 billion dong (£687,300) for the year to December 2012. 

WPP shares are now up 50% over the past 12 months.

AstraZeneca

The day got off to a good start for AstraZeneca (LSE: AZN) (NYSE: AZN.US), with a 59p (1.7%) boost to 3,596p, taking the price up more than 20% since this time last year.

Again there was an acquisition behind it, with the drugs giant telling us it “will acquire the entirety of Bristol-Myers Squibb’s interests in the companies’ diabetes alliance“. AstraZeneca will pay $2.7bn up front followed by up to $1.4bn depending on agreed performance targets, and there will be various other smaller sums applicable for royalties and some assets.

Since his arrival, chief executive Pascal Soriot has been focusing on the company’s core assets and strengths, and this is clearly a positive move in that direction.

Meggitt

Aerospace and defence engineer Meggitt (LSE: MGGT) has been awarded a contract worth US$18m by the Australian Defence Force, for providing hardware and software upgrades to a number of existing projects.

The deal comes on the heels of a number of big international contracts totalling $40m, from Italy, Kuwait, Singapore and the US.

Meggitt shares picked up 7.5p (1.5%) to 511p in response to the news. 

Alan does not own any shares mentioned in this article. 

More on Investing Articles

Picturesque Cotswold village of Castle Combe, England
Investing Articles

£567 passive income from a £7,000 Stocks and Shares ISA? Here’s how

Here's one FTSE 100 business investors might add to a Stocks and Shares ISA to instantly unlock an 8.1% dividend…

Read more »

Black woman using smartphone at home, watching stock charts.
Investing Articles

Why Amazon’s falling share price after strong Q4 earnings could be good news

Amazon’s share price is falling as the prospect of a $200bn spend in 2026 has investors nervous. But Stephen Wright…

Read more »

Older couple walking in park
Investing Articles

How much do I need in my ISA for a £1,000 monthly passive income?

Picking high-income stocks in an ISA can be a route to securing long-term passive income. And here's one with a…

Read more »

Smiling white woman holding iPhone with Airpods in ear
Investing Articles

Prediction: in 12 months the surging Aviva share price and dividend could turn £10,000 into…

Aviva's share price has beaten the broader FTSE 100 over the last year. But can the financial services giant keep…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Dividend Shares

I love FTSE 100 dividend shares, but do I buy this FTSE 250 loser?

Over the past year, the UK's FTSE 100 has thrashed the once-mighty US S&P 500 index. With value investing back…

Read more »

Investing Articles

How much do you need in an ISA to target a £2,000 monthly second income?

Harvey Jones crunches the numbers to see how much investors need in a Stocks and Shares ISA to generate a…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

Should investors consider Legal & General shares for passive income?

As many investors are chasing their passive income dreams, our writer Ken Hall evaluates whether Legal & General could help…

Read more »

ISA coins
Investing Articles

How to transform an empty Stocks and Shares ISA into a £15,000 second income

Ben McPoland explains how a UK dividend portfolio can be built from the ground up inside a Stocks and Shares…

Read more »